Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Asthma - management

  • Comparison of aerosol deposition pattern in healthy vs. asthmatic subjects
    Caroline Majoral, Ira Katz, John Fleming, Joy Conway, Lesley Collier, Marine Pichelin, Livia Tossici-Bolt, Georges Caillibotte
    European Respiratory Journal Sep 2012, 40 (Suppl 56) 166;
  • Reductions in exacerbations with omalizumab in a real-world setting
    Gert-Jan Braunstahl, Andreas Georgiou, Janice Canvin, Robert Maykut, Jennifer Bruce, Chien-Wei Chen
    European Respiratory Journal Sep 2012, 40 (Suppl 56) 198;
  • Accuracy in assessment of acute asthma needs improved to avoid potential adverse outcomes
    Selina Tsim, Lorraine Bridges, Grace Murphy, Peter Kewin
    European Respiratory Journal Sep 2012, 40 (Suppl 56) 193;
  • Improvement in asthma severity and control by voriconazole and posaconazole in severe asthma with fungal sensitization (SAFS) and ABPA
    Livingstone Chishimba, Robert Niven, David Denning
    European Respiratory Journal Sep 2012, 40 (Suppl 56) 199;
  • Mepolizumab (anti-IL-5) reduces exacerbations in patients with refractory eosinophilic asthma
    Ian Pavord, Stephanie Korn, Peter Howarth, Eugene Bleecker, Roland Buhl, Oliver Keene, Hector Ortega, Pascal Chanez
    European Respiratory Journal Sep 2012, 40 (Suppl 56) 349;

Pages

  • Previous
  • 1
  • …
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • 201
  • 202
  • 203
  • Acute lung injury and critical care (82)
  • Asthma and allergy (635)
  • CF and non-CF bronchiectasis (272)
  • COPD and smoking (902)
  • Epidemiology, occupational and environmental lung disease (212)
  • Genetics (58)
  • Interstitial and orphan lung disease (485)
  • Lung biology and experimental studies (309)
  • Lung cancer (277)
  • Lung imaging (41)
  • Lung structure and function (303)
  • Mechanisms of lung disease (144)
  • Paediatric pulmonology (392)
  • Pulmonary pharmacology and therapeutics (140)
  • Pulmonary vascular disease (509)
  • Respiratory clinical practice (167)
  • Respiratory infections and tuberculosis (949)
  • Sleep medicine (263)
  • Most Read
  • Twitter
Loading

Tweets by @ERSpublications

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society